US2009186092A1PendingUtilityA1

System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same

Assignee: RELIANT PHARMACEUTICALS INCPriority: Dec 22, 2006Filed: Aug 20, 2008Published: Jul 23, 2009
Est. expiryDec 22, 2026(~0.4 yrs left)· nominal 20-yr term from priority
Inventors:Hasmukh Patel
G01N 15/0272A61K 9/0004A61K 31/4439A61P 9/12
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A system and method for manufacturing oral osmotic drug delivery devices including the use of a mathematical model in deriving relationships between parameters used in manufacturing the devices for a desired release rate of the active drug substance contained therein. The derived relationship is then used to control the parameters so that the active substance within the device is delivered at a desired rate. Methods of administering the oral osmotic drug delivery devices are also provided. Use of a mathematical model in deriving relationships between parameters used in the drug granulation process for a desired range of percentage fines of the drug granulation substance. The derived relationship is then used to control the parameters in the drug granulation process so that the desired percentage fines are obtained in the drug granulation substance.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
   
   
       21 . A method, comprising manufacturing a plurality of oral osmotic drug delivery devices, each of which comprises a bi-layer core comprising (1) an active layer comprising particles of a mixture of isradipine and one or more excipients wherein the particles have a particle size distribution as determined by the percentage of the particles that pass through a #120 mesh screen, and (2) an osmotic layer, and a semi-permeable outer coating substantially surrounding the bi-layer core, by a method comprising obtaining a selected release rate by applying a relational mechanism relating the particle size distribution, a weight value of the plurality of bi-layer cores, and a weight value of the outer coating; and administering once daily to a subject one of the oral osmotic drug delivery devices. 
   
   
       22 . The method according to  claim 21 , wherein the relational mechanism is derived using a neural network. 
   
   
       23 . The method according to  claim 21 , wherein the relational mechanism is derived using multiple linear regression. 
   
   
       24 . The method according to  claim 21 , wherein the relational mechanism is derived using Monte Carlo simulation. 
   
   
       25 . The method according to  claim 21 , wherein the relational mechanism comprises a table.

Join the waitlist — get patent alerts

Track US2009186092A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.